In­fla­tion re­bates in­com­ing: Wyden calls on CMS to move quick­ly as No­var­tis CEO pledges re­ver­sal

Sen­ate Fi­nance Chair Ron Wyden (D-OR) this week sent a let­ter to the head of the Cen­ters for Medicare & Med­ic­aid Ser­vices seek­ing an up­date on how and when new in­fla­tion-linked re­bates will take ef­fect for drugs that see ma­jor price spikes.

The new­ly signed In­fla­tion Re­duc­tion Act re­quires man­u­fac­tur­ers to pay a re­bate to Medicare when they in­crease drug prices faster than the rate of in­fla­tion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER